Cargando…
Antimicrobial Treatment of Community-Acquired Pneumonia
Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines...
Autores principales: | Restrepo, Marcos I., Anzueto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119139/ https://www.ncbi.nlm.nih.gov/pubmed/15802167 http://dx.doi.org/10.1016/j.ccm.2004.10.006 |
Ejemplares similares
-
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005) -
The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005) -
Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010) -
Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study
por: Mortensen, Eric M, et al.
Publicado: (2008) -
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
por: Maselli, Diego J, et al.
Publicado: (2012)